Condition

Mixed Dyslipidemia clinical trials and research

• 6Clinical trials
• 6Countries

Newest Mixed Dyslipidemia clinical trials

All recruiting trials (6)

• MWX203: a medicine for mixed dyslipidemia given alone or with Inclisiran

  This phase 2 study tests MWX203 alone or with Inclisiran in adults with mixed dyslipidemia who don’t reach lipid goals on statins.

  Recruiting Phase 2 Shanghai Minwei Biotechnology Co., Ltd · Beijing, Beijing Municipality · NCT07803822

• Obicetrapib vs. bempedoic acid for high-risk high cholesterol patients

  This phase 3 study tests whether obicetrapib can lower LDL-C more than bempedoic acid in adults with primary non-familial hypercholesterolemia or mixed dyslipidemia who still have high LDL-C despite maximum tolerated therapy.

  Recruiting Phase 3 A. Menarini International Licensing S.A. · Stockton-on-Tees · NCT07614958

• Bempedoic Acid With Ezetiimibe in Adults with High Cholesterol or Mixed Dyslipidemia

  This study tests bempedoic acid alone or with ezetimibe in real-world adults with primary hypercholesterolemia or mixed dyslipidemia to see how safe and effective it is in routine care.

  Recruiting at 38 sites Daiichi Sankyo · Belo Horizonte and 37 other locations · NCT07206472

• Comparing the effects of two medications on healthy individuals

  This study tests how two medications work in healthy people to see if one is safer or more effective than the other.

  Recruiting Phase 1 Addpharma Inc. · Seoul · NCT06932705

• Evaluating the effectiveness and safety of a combination medication for cholesterol management

  This study is testing a new combination medication for cholesterol management to see if it works better and is safe for people who need a change in their current cholesterol treatment.

  Recruiting Boryung Pharmaceutical Co., Ltd · Seoul · NCT06314919

• Evaluating the effectiveness and safety of AD-218 for mixed dyslipidemia

  This study is testing if a new drug called AD-218 can help people with mixed dyslipidemia improve their cholesterol levels and overall health.

  Recruiting Phase 3 Addpharma Inc. · Daegu, Nam-gu · NCT05400317

Related topics

Quick answers

How many Mixed Dyslipidemia clinical trials are recruiting right now?

6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 6 countries. The most sites are in South Korea (3 trials), United Kingdom (1 trial), Brazil (1 trial), Hong Kong (1 trial), Thailand (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 2, Phase 2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →